- Home
- NEOV vs BYSI Comparison
NEOV vs BYSI Comparison
Compare NEOV & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.77
HOLD
Current Price
$2.23
Company Overview
Basic Information| Metric | NEOV | BYSI |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.2M | 79.0M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | NEOV | BYSI |
|---|---|---|
| Price | $3.77 | $2.23 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 232.5K | ★ 591.5K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,486,857.00 | N/A |
| Revenue This Year | $148.14 | N/A |
| Revenue Next Year | $6.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 486.23 | N/A |
| 52 Week Low | $1.80 | $0.98 |
| 52 Week High | $6.19 | $3.44 |
Technical Indicators
Market Signals| Indicator | NEOV | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | 42.08 | 55.99 |
| Support Level | $3.35 | $1.89 |
| Resistance Level | $3.93 | $2.16 |
| Average True Range (ATR) | 0.35 | 0.19 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 27.83 | 47.54 |
Price Performance
Historical Comparison NEOV
BYSI
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.